Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
Medial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in Covid-19 patients, after more than 100 scientists and medical professionals raised questions about integrity of data analysed in the study.
Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible.
US President Donald Trump is "feeling absolutely great" after taking a two-week dose of antimalarial drug hydroxychloroquine and would take it again if he feels he is exposed to the coronavirus, a top White House official has said.
Even as the World Health Organisation (WHO) halted the hydroxychloroquine arm of its COVID-19 drug trials on Monday, the Indian Council of Medical Research (ICMR) today said that there were no major side-effects of the malaria drug in the studies in India.
Hydroxychloroquine and azithromycin, which have been proposed for treatment of COVID-19 patients, are a potentially lethal combination, and may have a serious impact on the cardiovascular system, according to a study.
The World Health Organisation (WHO) has suspended the trials of hydroxychloroquine as COVID-19 treatment citing safety concerns.
Trump was addressing his disclosure last week that he was taking hydroxychloroquine and a zinc supplement. He said the regimen was meant to help prevent infection after two White House staffers tested positive for the coronavirus.
A revised government advisory on Friday recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection-related activities.
Treatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study.
A clinical trial has begun in the US to evaluate whether the anti-malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent COVID-19 hospitalization and death, according to the National Institutes of Health (NIH).
India has supplied paracetamol and hydroxychloroquine to over 120 countries in the last two months while ensuring the domestic supply, as these two medicines are in huge demand due to COVID-19, Commerce and Industry Minister Piyush Goyal said on Thursday.
COVID-19, which broke out first in China’s Hubei province, has caused havoc across the world, claiming the lives of more than 2.6 lakh people and infected over 37 lakh.
At a time when the anti-malarial drug hydroxychloroquine (HCQ) is being touted as a 'wonder drug' to treat critical COVID-19 patients, a new US study has found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at an increased risk of electrical changes to the heart and cardiac arrhythmias.
Several hospitals in the United States continue to use malaria drug hydroxychloroquine in the treatment of COVID-19 positive patients, a media report said.
A team of US doctors has claimed that hydroxychloroquine, an anti-malarial drug termed potential "game-changer" for COVID-19 by President Donald Trump, has improved the survival and recovery odds for about 90 per cent of patients infected with the virus.
Health workers involved in the treatment of coronavirus patients will be given hydroxychloroquine (HCQ) tablets as a preventive medication, the Maharashtra government has said and issued guidelines on the use of the drug.
Coronavirus in India: According to a new set of guidelines issued on Monday, the patient should be clinically assigned as a very mild case or pre-symptomatic case by the treating medical officer.
Patients with COVID-19 who were on a regimen of the drugs hydroxychloroquine and azithromycin experienced cardiac abnormalities, according to a study which recommends the continuous monitoring of heart beat rhythms in infected people with underlying health conditions.
FDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and used in limited circumstances, such as for certain hospitalised patients with COVID-19.
Top News
Latest News
